MYBL2 and neoplasm: Eight genes exhibited greater than 340-fold increases in expression in tumor tissues (CLDN6, KLK7, WNT10A, MYBL2, MAL2, KRT7, PRSS8, EPCAM; Median (Range) of fold increase = 344 (261–7267)).